- Are sodium-glucose co-transporter-2 inhibitors associated with improved outcomes in diabetic patients admitted to intensive care units with septic shock?
-
Ashcherkin N, Abdalla AA, Gupta S, Bhatt S, Yee CI, Cartin-Ceba R
- KMID: 2557241
- Acute Crit Care.
- 2024 May;39(2):251-256.
- doi: 10.4266/acc.2023.01046
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce organ dysfunction in renal and cardiovascular disease. There are limited data on the role of SGLT2i in acute organ dysfunction.... -
- CITED
-
- Close
- SHARE
-
- Close
